Âé¶¹´«Ã½É«Ç鯬

Journal News

Stabilizing the enzyme in fish odor syndrome

Mussa Quareshy
By Mussa Quareshy
Dec. 6, 2020

Fish odor syndrome, or trimethylaminuria, is a disease in which the liver cannot break down the smelly chemical trimethylamine, or TMA, that is produced by enzymes from bacteria residing in the gut. There is no cure for fish odor syndrome, which gives people an unpleasant fishy smell that can affect breath, sweat, urine and vaginal fluids.

FishOdor-226x600.jpg
University of Warwick
Top: protein crystals of CntA enzyme; middle: a cartoon depiction of CntA enzyme in its functional trimeric state; bottom: detailed view of carnitine bound in the active site of CntA prior to cleavage.

Our research team at the University of Warwick is working to prevent the syndrome through studying the enzyme in the gut that produces trimethylamine.

Fish odor syndrome starts when an enzyme pathway in the gut called CntA/B produces TMA. The enzyme breaks down a TMA precursor called L-carnitine, which is found in dairy, fish and meat. If an individual lacks a functional liver enzyme called FMO3, they cannot degrade TMA into a non-smelly chemical form, trimethylamine oxide, or TMAO. The TMA then builds up in the body and ends up in bodily fluids.

In, published in the Journal of Biological Chemistry, our team in at Warwick's School of Life Sciences focused on the CntA protein of the CntA/B enzyme, to stabilize and study it.

CntA/B is a notoriously hard enzyme to study, but once it was stabilized, we were able to gain insight into how CntA perceives its L-carnitine substrate with a 3D crystal structure model, and by studying the complete electron transfer pathway, we could see how the protein is able to turn over TMA.

Now that we understand how exactly TMA is produced in the gut and that the enzyme can be inhibited, there are grounds for further research into future discovery of drugs targeting the TMA-producing enzyme in the human gut.

We have identified novel, drug-like inhibitors that can inhibit CntA function and thus TMA formation with the potential to attenuate TMA formation in the gut microbiome. This is vital not only for people who have fish odor syndrome, but also because TMA can accelerate atherosclerosis and heart disease.
 

This article was adapted from a University of Warwick press release. Read the original .

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Mussa Quareshy
Mussa Quareshy

Mussa Quareshy grew up in Malawi, then moved to the U. K. where he earned a master’s degree in pharmaceutical sciences at the University of Leicester and a Ph.D. at Warwick University, studying the plant hormone Auxin and its receptor. He is a postdoc research fellow in Yin Chen’s lab in the School of Life Sciences at Warwick where his research interests are primarily studying protein ligand interactions with an interest in drug discovery projects.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

ApoA1 reduce atherosclerotic plaques via cell death pathway
Journal News

ApoA1 reduce atherosclerotic plaques via cell death pathway

Oct. 1, 2025

Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
Journal News

Omega-3 lowers inflammation, blood pressure in obese adults

Oct. 1, 2025

A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.

AI unlocks the hidden grammar of gene regulation
Feature

AI unlocks the hidden grammar of gene regulation

Sept. 30, 2025

Using fruit flies and artificial intelligence, Julia Zeitlinger’s lab is decoding genome patterns — revealing how transcription factors and nucleosomes control gene expression, pushing biology toward faster, more precise discoveries.

Zebrafish model links low omega-3s to eye abnormalities
Journal News

Zebrafish model links low omega-3s to eye abnormalities

Sept. 24, 2025

Researchers at the University of Colorado Anschutz developed a zebrafish model to show that low maternal docosahexaenoic acid can disrupt embryo eye development and immune gene expression, offering a tool to study nutrition in neurodevelopment.

Top reviewers at ASBMB journals
Observance

Top reviewers at ASBMB journals

Sept. 19, 2025

Editors recognize the heavy-lifters and rising stars during Peer Review Week.

Teaching AI to listen
Essay

Teaching AI to listen

Sept. 18, 2025

A computational medicine graduate student reflects on building natural language processing tools that extract meaning from messy clinical notes — transforming how we identify genetic risk while redefining what it means to listen in science.